Niamh Chapman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Niamh Chapman has a total of 287 co-authors. Here are the top co-authors by number of shared publications:
- Dean S. Picone
School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
15 shared publications - Aletta Elisabeth Schutte
North‐West University
12 shared publications - James Edward Sharman
Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia
12 shared publications - Eleanor Clapham
Menzies Institute for Medical Research, University of Tasmania
7 shared publications John Stevens
Menzies Institute for Medical Research, University of Tasmania, Australia
6 shared publications- Francine Zanchetta Coelho Marques
Hypertension Research Laboratory, Department of Pharmacology, Biomedical Discovery Institute, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia
5 shared publications
Latest Publications
- Open Access
- 24 May 2026
- Published by Elsevier in Patient Education and Counseling
- Vol. 149, 109707
Patient personas exemplifying behavioural barriers and enablers to patient education across the hypertension journey: A qualitative framework analysis
- 24 May 2026
- Published by Elsevier in Patient Education and Counseling
- Vol. 149, 109707
Open AccessPatient personas exemplifying behavioural barriers and enablers to patient education across the hypertension journey: A qualitative framework analysis
- Top Cited PapersOpen Access
- 9 May 2026
- Published by Elsevier in The Lancet Primary Care
- Vol. 2 (5)
HEARTS 2.0: an implementation-oriented clinical pathway for integrated care of hypertension and cardiovascular–kidney–metabolic conditions in primary health care in the Americas
- 9 May 2026
- Published by Elsevier in The Lancet Primary Care
- Vol. 2 (5)
Top Cited PapersOpen AccessHEARTS 2.0: an implementation-oriented clinical pathway for integrated care of hypertension and cardiovascular–kidney–metabolic conditions in primary health care in the Americas
- Top Cited PapersOpen Access
- 22 April 2026
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 39 (8) , 956-965
Evidence-informed prioritization of interventions for integrating hypertension management into cardiovascular-kidney-metabolic care in primary health care: HEARTS 2.0 Phase 3
Background: HEARTS in the Americas is the regional adaptation of the WHO Global HEARTS Initiative. This paper presents Phase 3 of HEARTS 2.0, an evidence-informed process to prioritize clinical and health-system interventions to support the operationalization of integrated cardiovascular, kidney, and metabolic (CKM) care in primary health care (PHC) and to inform the update of the HEARTS Clinical Pathway. CKM conditions frequently coexist, sharing common risk factors and pathophysiological mechanisms that exacerbate cardiovascular disease burden. Despite their overlap, clinical practice often remains siloed due to condition-specific guidelines, and its integration remains limited. To prioritize evidence-informed clinical and health-system interventions that support the operationalization of integrated CKM care within PHC and inform the update of the HEARTS Clinical Pathway. Methods: Building on previous phases of HEARTS 2.0, a multidisciplinary panel evaluated 45 candidate interventions in different areas. The selection process utilized structured evidence appraisal, Evidence-to-Decision frameworks, and a modified RAND/UCLA appropriateness method involving anonymized rating rounds. Results: A total of 38 interventions were prioritized for implementation. Although hypertension management remains the primary entry point, the resulting framework integrates early detection of diabetes and chronic kidney disease, lifestyle interventions, risk-based combination pharmacotherapy, task-sharing, and longitudinal follow-up. Conclusions: By translating dispersed guideline recommendations into implementable interventions, Phase 3 of HEARTS 2.0 provides an evidence-informed basis for advancing integrated CKM care at scale in PHC and guiding the forthcoming update of the HEARTS Clinical Pathway. The resulting framework offers a flexible, scalable approach for countries confronting similar epidemiological and health system challenges.
- 22 April 2026
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 39 (8) , 956-965
Top Cited PapersOpen AccessEvidence-informed prioritization of interventions for integrating hypertension management into cardiovascular-kidney-metabolic care in primary health care: HEARTS 2.0 Phase 3
Background: HEARTS in the Americas is the regional adaptation of the WHO Global HEARTS Initiative. This paper presents Phase 3 of HEARTS 2.0, an evidence-informed process to prioritize clinical and health-system interventions to support the operationalization of integrated cardiovascular, kidney, and metabolic (CKM) care in primary health care (PHC) and to inform the update of the HEARTS Clinical Pathway. CKM conditions frequently coexist, sharing common risk factors and pathophysiological mechanisms that exacerbate cardiovascular disease burden. Despite their overlap, clinical practice often remains siloed due to condition-specific guidelines, and its integration remains limited. To prioritize evidence-informed clinical and health-system interventions that support the operationalization of integrated CKM care within PHC and inform the update of the HEARTS Clinical Pathway. Methods: Building on previous phases of HEARTS 2.0, a multidisciplinary panel evaluated 45 candidate interventions in different areas. The selection process utilized structured evidence appraisal, Evidence-to-Decision frameworks, and a modified RAND/UCLA appropriateness method involving anonymized rating rounds. Results: A total of 38 interventions were prioritized for implementation. Although hypertension management remains the primary entry point, the resulting framework integrates early detection of diabetes and chronic kidney disease, lifestyle interventions, risk-based combination pharmacotherapy, task-sharing, and longitudinal follow-up. Conclusions: By translating dispersed guideline recommendations into implementable interventions, Phase 3 of HEARTS 2.0 provides an evidence-informed basis for advancing integrated CKM care at scale in PHC and guiding the forthcoming update of the HEARTS Clinical Pathway. The resulting framework offers a flexible, scalable approach for countries confronting similar epidemiological and health system challenges.
- 19 March 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (12) , 2301-2303
Inequalities in cardiovascular trial representation in low- and middle-income countries
Surabhi Kumble Basnayake, MBBS, MPH, Niamh Chapman, Priyanka Pandita, Amit Arora, Aletta E Schutte, Shiva Raj Mishra, MPH, PhD; Inequalities in cardiovascu
- 19 March 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (12) , 2301-2303
Inequalities in cardiovascular trial representation in low- and middle-income countries
Surabhi Kumble Basnayake, MBBS, MPH, Niamh Chapman, Priyanka Pandita, Amit Arora, Aletta E Schutte, Shiva Raj Mishra, MPH, PhD; Inequalities in cardiovascu
- Open Access
Hypertension detection, treatment and control in young adults in Australia
Background: Young adult hypertension increases risk of future cardiovascular disease (CVD) but is often overlooked. We aimed to identify opportunities to reduce blood pressure (BP) among younger adults by determining the drivers of hypertension detection, treatment and control in young adults in Australia. Methods: Cross-sectional analysis of adults aged 18–39 years using nationally representative 2017-18 Australian National Health Survey data. Descriptive analyses were performed to determine hypertension prevalence, detection, treatment and control by sex, health services interaction, geographical location and socioeconomic status, with subgroup analyses among those with co-existing cardiometabolic risk factors. Hypertension was defined as self-reported diagnosis, treatment, and/or measured BP≥140/90mmHg. Detection was defined as self-reported hypertension, treatment as taking ≥1 antihypertensive class, and control as BP<140/90mmHg. Results: The survey sample (n=5,217) was representative of N=7,533,625 adults aged 18–39 years (49.9% women). Hypertension prevalence was 11.2% (95% CI: 11.1% to 11.2%). Among those with hypertension, detection was 13.5%, treatment was 6.5% and control was 4.3%. These rates were influenced by factors related to healthcare access, for example, young adults who had a recent BP check and resided in major cities had higher rates than their counterparts. Conclusions: One in ten young Australians adult have hypertension, yet only 13.5% are detected. Differences in detection, treatment and control rates were partly explained by factors related to healthcare access. There is a need to better detect and manage high BP in young adults, potentially by developing tailored approaches that are specific to different contexts and ultimately supporting prevention of CVD in later life.
Open AccessHypertension detection, treatment and control in young adults in Australia
Background: Young adult hypertension increases risk of future cardiovascular disease (CVD) but is often overlooked. We aimed to identify opportunities to reduce blood pressure (BP) among younger adults by determining the drivers of hypertension detection, treatment and control in young adults in Australia. Methods: Cross-sectional analysis of adults aged 18–39 years using nationally representative 2017-18 Australian National Health Survey data. Descriptive analyses were performed to determine hypertension prevalence, detection, treatment and control by sex, health services interaction, geographical location and socioeconomic status, with subgroup analyses among those with co-existing cardiometabolic risk factors. Hypertension was defined as self-reported diagnosis, treatment, and/or measured BP≥140/90mmHg. Detection was defined as self-reported hypertension, treatment as taking ≥1 antihypertensive class, and control as BP<140/90mmHg. Results: The survey sample (n=5,217) was representative of N=7,533,625 adults aged 18–39 years (49.9% women). Hypertension prevalence was 11.2% (95% CI: 11.1% to 11.2%). Among those with hypertension, detection was 13.5%, treatment was 6.5% and control was 4.3%. These rates were influenced by factors related to healthcare access, for example, young adults who had a recent BP check and resided in major cities had higher rates than their counterparts. Conclusions: One in ten young Australians adult have hypertension, yet only 13.5% are detected. Differences in detection, treatment and control rates were partly explained by factors related to healthcare access. There is a need to better detect and manage high BP in young adults, potentially by developing tailored approaches that are specific to different contexts and ultimately supporting prevention of CVD in later life.
- Open Access
Developing implementation strategies to improve patient education for hypertension in primary care
Background: Effective education improves hypertension self-management but is not routinely delivered, and there is limited guidance to overcome barriers to support delivery in primary care. This study aimed to use co-design and an implementation science framework to develop and prioritize implementation strategies for the delivery of patient education to support blood pressure (BP) management across the hypertension journey in primary care. Methods: A two-stage, co-design study using implementation science frameworks. Stage 1 involved mapping interviews with patients to the Consolidated Framework for Implementation Research and Expert Recommendations for Implementing Change to generate strategies to improve patient education for BP management along the care journey (diagnosis, treatment initiation, long-term management). Stage 2 involved a three-hour multi-disciplinary workshop to refine, rank and prioritize these strategies using patient personas, clinical scenarios, and participatory voting. Finally, the strategies were reviewed by consumer advisors with lived experience of BP management to ensure suitability and acceptability. Results: Six context-specific strategy prompts aligned to stages of the hypertension journey were paired with patient personas and clinical scenarios to guide workshop discussions. Twenty-one participants (n=2 general practitioners, n=4 nurses, n=6 pharmacists, n=10 industry professionals) attended the workshop. Ultimately, six refined strategies included: (1) in-pharmacy education for suitable device purchase using a structured protocol; (2) general practitioner consultations about home BP measurement with nurse follow-up; (3) nurse-led drop-in group education sessions; (4) nurse-led group education on interpreting readings with general practitioner follow-up; (5) nurse-led lifestyle planning with allied health referrals; and (6) pharmacist-delivered BP measurement and medication review. Pharmacy-based strategies (1) and (6) ranked highest for feasibility and impact, and cost-effectiveness, respectively. Conclusion: We identified evidence-based multidisciplinary strategies to improve the delivery of patient education for hypertension, co-designed with clinicians. Future work should focus on evaluating their implementation in real-world primary care settings. KEY MESSAGES: What is already known on this topic: Patient education improves hypertension self-management, yet it is rarely delivered consistently in primary care and there is limited guidance on how to overcome practical barriers to implementing education strategies across the care journey. What this study adds: This study co-designed and prioritized six multidisciplinary, context-specific strategies to deliver patient education for blood pressure management at diagnosis, treatment initiation, and long-term care, using implementation science frameworks. How this study might affect research, practice or policy: These strategies offer a practical roadmap for embedding structured education into routine primary care by leveraging existing workforce and infrastructure, aligning with funded models, and supported by clinician incentives to enhance uptake.
Open AccessDeveloping implementation strategies to improve patient education for hypertension in primary care
Background: Effective education improves hypertension self-management but is not routinely delivered, and there is limited guidance to overcome barriers to support delivery in primary care. This study aimed to use co-design and an implementation science framework to develop and prioritize implementation strategies for the delivery of patient education to support blood pressure (BP) management across the hypertension journey in primary care. Methods: A two-stage, co-design study using implementation science frameworks. Stage 1 involved mapping interviews with patients to the Consolidated Framework for Implementation Research and Expert Recommendations for Implementing Change to generate strategies to improve patient education for BP management along the care journey (diagnosis, treatment initiation, long-term management). Stage 2 involved a three-hour multi-disciplinary workshop to refine, rank and prioritize these strategies using patient personas, clinical scenarios, and participatory voting. Finally, the strategies were reviewed by consumer advisors with lived experience of BP management to ensure suitability and acceptability. Results: Six context-specific strategy prompts aligned to stages of the hypertension journey were paired with patient personas and clinical scenarios to guide workshop discussions. Twenty-one participants (n=2 general practitioners, n=4 nurses, n=6 pharmacists, n=10 industry professionals) attended the workshop. Ultimately, six refined strategies included: (1) in-pharmacy education for suitable device purchase using a structured protocol; (2) general practitioner consultations about home BP measurement with nurse follow-up; (3) nurse-led drop-in group education sessions; (4) nurse-led group education on interpreting readings with general practitioner follow-up; (5) nurse-led lifestyle planning with allied health referrals; and (6) pharmacist-delivered BP measurement and medication review. Pharmacy-based strategies (1) and (6) ranked highest for feasibility and impact, and cost-effectiveness, respectively. Conclusion: We identified evidence-based multidisciplinary strategies to improve the delivery of patient education for hypertension, co-designed with clinicians. Future work should focus on evaluating their implementation in real-world primary care settings. KEY MESSAGES: What is already known on this topic: Patient education improves hypertension self-management, yet it is rarely delivered consistently in primary care and there is limited guidance on how to overcome practical barriers to implementing education strategies across the care journey. What this study adds: This study co-designed and prioritized six multidisciplinary, context-specific strategies to deliver patient education for blood pressure management at diagnosis, treatment initiation, and long-term care, using implementation science frameworks. How this study might affect research, practice or policy: These strategies offer a practical roadmap for embedding structured education into routine primary care by leveraging existing workforce and infrastructure, aligning with funded models, and supported by clinician incentives to enhance uptake.
- 1 January 2026
- Published by Human Kinetics in Journal of Physical Activity and Health
- p. 1-12
Boosting Everyday Movement: Codesigning a Digital Micropatterns Intervention With Socioeconomically Diverse UK and Australian Communities
Background : “Micropatterns” refer to brief bouts of nonexercise physical activity ( Methods : The study involved a series of codesign workshops in each country. Participants were nonexercising adults aged 30+ (n = 20 in Scotland and n = 34 in Australia). Workshops drew on the behavior change wheel to explore facilitators and barriers to micropatterns and codesign the intervention. Data were analyzed using thematic framework analysis. Results : Participants identified a range of barriers (eg, aging and physical decline) and facilitators (eg, valuing health benefits) to engaging in micropatterns. Four modifiable factors were identified: a lack of knowledge and awareness, perceptions about energy and effort, concerns about ability and safety, and low mood and poor mental health. Participants identified 13 intervention components utilizing 6 intervention functions (eg, education, persuasion, and training), and a program theory was developed. To deliver the change mechanism, participants emphasized the importance of inclusive educational content and digital accessibility. Conclusions : This study demonstrated the theoretically grounded development of a smartphone intervention to promote micropatterns among socioeconomically diverse communities. Future research is required to test the feasibility of the intervention while ensuring digital accessibility and the availability of social support.
- 1 January 2026
- Published by Human Kinetics in Journal of Physical Activity and Health
- p. 1-12
Boosting Everyday Movement: Codesigning a Digital Micropatterns Intervention With Socioeconomically Diverse UK and Australian Communities
Background : “Micropatterns” refer to brief bouts of nonexercise physical activity ( Methods : The study involved a series of codesign workshops in each country. Participants were nonexercising adults aged 30+ (n = 20 in Scotland and n = 34 in Australia). Workshops drew on the behavior change wheel to explore facilitators and barriers to micropatterns and codesign the intervention. Data were analyzed using thematic framework analysis. Results : Participants identified a range of barriers (eg, aging and physical decline) and facilitators (eg, valuing health benefits) to engaging in micropatterns. Four modifiable factors were identified: a lack of knowledge and awareness, perceptions about energy and effort, concerns about ability and safety, and low mood and poor mental health. Participants identified 13 intervention components utilizing 6 intervention functions (eg, education, persuasion, and training), and a program theory was developed. To deliver the change mechanism, participants emphasized the importance of inclusive educational content and digital accessibility. Conclusions : This study demonstrated the theoretically grounded development of a smartphone intervention to promote micropatterns among socioeconomically diverse communities. Future research is required to test the feasibility of the intervention while ensuring digital accessibility and the availability of social support.
- Open Access
Patient personas exemplifying behavioural barriers and enablers to patient education across the hypertension journey: A qualitative framework analysis
Background.: Only one in five people with hypertension have their blood pressure (BP) controlled (<140/90 mmHg). Patient education improves BP control, yet there is limited guidance to adapt to individuals’ evolving needs across the hypertension management journey. This study aimed to identify key behavioural barriers and enablers to patient education throughout the hypertension management journey, which were synthesised into patient personas to support translation and practical application. Methods.: Qualitative interviews with adults (≥18) who self-monitor BP, and primary care providers involved in hypertension care. Interviews explored the experience of accessing and delivering patient education for BP measurement and management. Using framework analysis, patient personas were developed in three steps: 1) thematic analysis of patient interviews to identify key barriers and enablers to hypertension patient education and mapping the identified barriers and enablers to key time-points in the hypertension journey (diagnosis, treatment initiation, long-term management), 2) clustering behavioural factors via the capability, opportunity, motivation-behaviour model, which were then synthesised as preliminary patient personas and refined using practitioner interviews and, 3) validation by consumer consultation feedback sessions. Results.: Patients (n=27) and practitioners (n=12; n=4 general practitioners, n=4 nurses, and n=4 pharmacists) were aged 18-60 years (52% of patients and 100% of practitioners fell within this age range). Several behavioural barriers to patient education for hypertension management included patient overwhelm, inconsistent guidance provided by health professionals, and perceived patient disengagement, while a strong desire to self-manage was a consistent enabler. Six clusters of behavioural barriers and enablers were synthesised as patient personas, capturing the factors that shape education needs and experiences across the hypertension management journey. Conclusions.: The patient personas highlight opportunities for tailored patient education strategies through the development of patient personas. Practice implications.: The patient personas provide a practical tool for designing person-centred interventions in primary care.
Open AccessPatient personas exemplifying behavioural barriers and enablers to patient education across the hypertension journey: A qualitative framework analysis
Background.: Only one in five people with hypertension have their blood pressure (BP) controlled (<140/90 mmHg). Patient education improves BP control, yet there is limited guidance to adapt to individuals’ evolving needs across the hypertension management journey. This study aimed to identify key behavioural barriers and enablers to patient education throughout the hypertension management journey, which were synthesised into patient personas to support translation and practical application. Methods.: Qualitative interviews with adults (≥18) who self-monitor BP, and primary care providers involved in hypertension care. Interviews explored the experience of accessing and delivering patient education for BP measurement and management. Using framework analysis, patient personas were developed in three steps: 1) thematic analysis of patient interviews to identify key barriers and enablers to hypertension patient education and mapping the identified barriers and enablers to key time-points in the hypertension journey (diagnosis, treatment initiation, long-term management), 2) clustering behavioural factors via the capability, opportunity, motivation-behaviour model, which were then synthesised as preliminary patient personas and refined using practitioner interviews and, 3) validation by consumer consultation feedback sessions. Results.: Patients (n=27) and practitioners (n=12; n=4 general practitioners, n=4 nurses, and n=4 pharmacists) were aged 18-60 years (52% of patients and 100% of practitioners fell within this age range). Several behavioural barriers to patient education for hypertension management included patient overwhelm, inconsistent guidance provided by health professionals, and perceived patient disengagement, while a strong desire to self-manage was a consistent enabler. Six clusters of behavioural barriers and enablers were synthesised as patient personas, capturing the factors that shape education needs and experiences across the hypertension management journey. Conclusions.: The patient personas highlight opportunities for tailored patient education strategies through the development of patient personas. Practice implications.: The patient personas provide a practical tool for designing person-centred interventions in primary care.
- Open Access
- 16 December 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (24) , e042797
Revisiting Unattended Versus Attended Automated Office Blood Pressure Measurements: A Systematic Review and Meta‐Analysis
Background: Standardized automated office blood pressure (AOBP) measurement is widely accepted as the preferred method for monitoring blood pressure (BP) in health care settings. However, disagreements persist as to the need to perform AOBP unattended, where the patient is left alone in a quiet room. Thus, this study aimed to assess the BP differences between unattended and attended AOBP. Methods: This systematic review and meta‐analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines and registered on PROSPERO (International Prospective Register of Systematic Reviews). Studies were included if unattended and attended AOBP measurements were performed on the same participants in a randomized or alternating sequence order during a single visit, using the same device and measurement protocol. The primary outcome was the difference between unattended and attended systolic BP and the secondary outcome, the difference in diastolic BP. Pooled results were expressed as weighted mean differences (95% CI) obtained using random‐effects meta‐analysis. Results: From 8088 screened studies, data were extracted from 15 studies (n=1747 participants). The unattended systolic BP and diastolic BP were −2.7 (−4.7 to −0.6) and −0.9 (−1.8 to −0.1) mm Hg lower than attended BPs. In a leave‐one‐out analysis, the overall difference was largely driven by a single outlier study. After excluding that study, the estimated difference was −2.0 mmHg (95% CI −4.1 to 0.0). Conclusions: Standardized unattended AOBP measurements result in slightly lower readings than attended AOBP. Whether these small measurement differences translate into clinically significant changes in management remains uncertain. Therefore, attended AOBP appears to be a reasonable option for BP measurement in a real‐world clinical setting.
- 16 December 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (24) , e042797
Open AccessRevisiting Unattended Versus Attended Automated Office Blood Pressure Measurements: A Systematic Review and Meta‐Analysis
Background: Standardized automated office blood pressure (AOBP) measurement is widely accepted as the preferred method for monitoring blood pressure (BP) in health care settings. However, disagreements persist as to the need to perform AOBP unattended, where the patient is left alone in a quiet room. Thus, this study aimed to assess the BP differences between unattended and attended AOBP. Methods: This systematic review and meta‐analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines and registered on PROSPERO (International Prospective Register of Systematic Reviews). Studies were included if unattended and attended AOBP measurements were performed on the same participants in a randomized or alternating sequence order during a single visit, using the same device and measurement protocol. The primary outcome was the difference between unattended and attended systolic BP and the secondary outcome, the difference in diastolic BP. Pooled results were expressed as weighted mean differences (95% CI) obtained using random‐effects meta‐analysis. Results: From 8088 screened studies, data were extracted from 15 studies (n=1747 participants). The unattended systolic BP and diastolic BP were −2.7 (−4.7 to −0.6) and −0.9 (−1.8 to −0.1) mm Hg lower than attended BPs. In a leave‐one‐out analysis, the overall difference was largely driven by a single outlier study. After excluding that study, the estimated difference was −2.0 mmHg (95% CI −4.1 to 0.0). Conclusions: Standardized unattended AOBP measurements result in slightly lower readings than attended AOBP. Whether these small measurement differences translate into clinically significant changes in management remains uncertain. Therefore, attended AOBP appears to be a reasonable option for BP measurement in a real‐world clinical setting.